Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Počet burz, na kterých se obchodují akcie společnosti: 3. Na této stránce — cena a graf, dividendy, největší akcionáři a historie počtu akcií.
O Společnosti
- Web
- revvity.com
- Sektor
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Sídlo
- Waltham, United States
- Generální Ředitel
- Prahlad R. Singh
- Zaměstnanci
- 11 000
- Akcie v Oběhu
- 111.59 mil. k 2026-08-06
- Volně Obchodovatelné Akcie
- 102.49 mil.
- Tržní Kapitalizace
- 16.63 mld. USD
- Insideři
- 0.26%
- Instituce
- 96.55%
- Odvětví (SIC)
- Laboratory Analytical Instruments
- Právní Forma
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- Výplatní Poměr
- 13.4%
- FCF
- 558 mil. USD
- Payout / FCF
- 6%
- Dluh
- 3.21 mld. USD3.9 r. FCF
- Dividendová Řada
- 43 r.
- Zisk, FCF a vyplacené dividendy — za 12 měsíců do 05.07.2026 (poslední zpráva společnosti).
Popis
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Dividendy
Revvity Inc. (RVTY) vyplácí dividendy čtvrtletně. Za rok (12 měsíců až do poslední oznámené platby): 0.28 USD na akcii (platby: 4). To je asi 0.18% současné ceny akcií. Další datum ex-dividendy je 23.10.2026: 0.07 USD na akcii, výplata 13.11.2026. Roky nepřerušených dividend: 43.
| Ex-Dividendový Den | Výplata | Částka | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 oznámeno | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | čtvrtletní | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.1/0.3 % | čtvrtletní | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.1/0.3 % | čtvrtletní | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.1/0.2 % | čtvrtletní | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.1/0.3 % | čtvrtletní | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.1/0.3 % | čtvrtletní | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.1/0.3 % | čtvrtletní | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.1/0.2 % | čtvrtletní | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.1/≈0.2 % | čtvrtletní | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/≈0.2 % | čtvrtletní | US:RVTY |
| 2024-04-18 | 2024-05-10 | 0.0700 USD | 0.0/≈0.2 % | čtvrtletní | US:RVTY |
Zprávy Tento Týden
Tiskové zprávy z investorských webových stránek společnosti, aktualizované denně. Odkazy vedou na webové stránky společnosti. Titulky jsou v původním jazyce, stejně jako na webových stránkách společnosti.
| 06.10.2026 | Revvity to Host Investor Day |
Největší Držitelé
| Držitel | Podíl | Akcie | Datum Zprávy |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 mil. | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 mil. | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 mil. | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 mil. | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 mil. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 mil. | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 mil. | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 mil. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 mil. | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 mil. | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 mil. | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 mil. | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 mil. | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 mil. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 mil. | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 mil. | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 mil. | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 mil. | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 mil. | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
